ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/10/2026
Back to search
Official data from USPTO
ITM PASSION FOR PRECISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
08/10/2026
Trademark type
Combined
Nice classes
5, 10, 42, 44
Filing date
01/04/2021
Registration date
11/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2021
Last transaction
08/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
94
Owner location
GARCHING, EU
Examiner
WILKE, JOHN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized letters "ITM" with two dots coming from the top of the "i" all positioned above the phrase "PASSION FOR PRECISION".
Holders and representatives
Holders
I. S. (pessoa física)
ITM Isotopen Technologien München AG
Representatives
KARI MOYER-HENRY LEWIS KOHN & WALKER LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radiopharmaceutical diagnostic and therapeutic preparations for medical purposesin particular radiopharmaceutical preparations for endo-radionuclide therapybrachytherapy and radiopharmaceutical preparations for positron emission tomography (PET) or single photon emission tomography (SPECT)target radionuclide and peptide receptor radionuclide therapy (PRRT); theranostics in the field of precision oncology; radiopharmaceutical productslutetium-containing precursors; solutions for radioactive labelling; radiopharmaceutical preparations for use in oncologyradiopharmaceuticals containing radioisotopese.g. lutetium-177actinium-225yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumors; target radiopharmaceuticals containing a target moleculee.g. peptide or antibodydepending on the indication and a medical radioactive isotope; radiopharmaceuticals containing gallium and its complexesgallium-68 DOTATOC; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET); radiopharmaceuticals for use in the therapy of GEP-NETosteosarcomabone metastasesprostate cancerbreast cancerbrain cancerovarian cancer; radiopharmaceuticals containing radioisotopes with short half-livessuch as gallium-68 or fluorine-18 for diagnostic applications; radiopharmaceuticals for use with high-sensitivity molecular imaging technologies such as PET (positron emission tomography) or SPECT (single photon emission tomography)for imaging organs and lesions and for early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-livesin particular lutetium-177actinium-225 or yttrium-90 for the treatment of tumor diseases
Class 10
Medical instrumentsapparatus and containers for the application of radiopharmaceutical and radiodiagnostic preparations; controlregulating and measuring apparatus as parts of medical instrumentsapparatus and containers included in this classin particular apparatus for therapy and diagnosis with a radiotherapeutic or radiodiagnostic substance; radionuclide generators for radiopharmaceutical purposes
Class 42
Conducting clinical trials in all stages and with various indicationsparticularly in oncology; conducting phase III clinical trials with target radiopharmaceutical 177Lu-Edotreotide in patients with neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET)
Class 44
Medical servicesin particular services in the field of radiotherapeutic and radiodiagnostic oncologycardiologyangiologyneuroradiology and nuclear medicine and brachytherapyincluding intercavitaryinterstitial and intravascular brachytherapyradionuclide labellingPET and SPECT scanning and target radionuclide therapypeptide receptor radionuclide therapy (PRRT)personal nuclear medicine and precision oncology
Publications
History of USPTO decisions and trademark events.
13 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
01/28/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/28/2021
NWAP
NEW APPLICATION ENTERED
01/07/2021
Continuous trademark protection
Get notified about every new filing that threatens ITM PASSION FOR PRECISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.